Five novel mutations and two large deletions in a population analysis of the phenylalanine hydroxylase gene
- PMID: 22513348
- DOI: 10.1016/j.ymgme.2012.03.015
Five novel mutations and two large deletions in a population analysis of the phenylalanine hydroxylase gene
Abstract
Mutational spectrum of the phenylalanine hydroxylase (PAH) deficiency was investigated in 107 families (90% of the Slovene PKU population). The entire coding region of the PAH gene was analyzed with dHPLC to select the samples where subsequently the automated sequencing analysis was performed. MLPA analysis was performed to identify large deletions, which were later confirmed with long-range PCR. Correlations with patients' phenotypes and genotype-based predictions of BH(4)-responsiveness were assessed. Altogether, disease-causing mutations were identified on 209 alleles (detection rate 97.7%). A spectrum of 36 different disease-causing mutations was identified: 20 missense mutations (80% of the alleles), eight splicing mutations (13% of the alleles), one nonsense mutation (0.5% of the alleles), four small deletions with frame shift (6% of the alleles), one small insertion with frame shift (0.5% of the alleles), and two large deletions (2% of the alleles). The most frequent mutation was p.R408W in exon 12, representing 29% of the alleles, which is in concordance with other neighboring and/or Slavic PKU populations. Other common mutations were: p.R158Q, p.A403V, p.P281L and p.E390G, accounting for 9%, 7%, 7% and 7% of the alleles respectively. Five novel mutations were detected: c.43_44insAG, c.56_59+1delACAGG, p.V45A, p.L62P and p.R157S. Large deletion of exon 5 (EX5del955) was found in three patients and a deletion of exon 3 (EX3del4765) in one patient. A spectrum of 64 different genotypes was found, seven of them accounting for over than a third of all families. Among thirteen families with homozygous mutation (13% of the PKU population), 10 had p.R408W, two had p.R158Q and one had p.E390G. Among 107 families, 58 were classified as classic PKU (54.2%), 28 as mild PKU (25.9%) and 21 as MHP (19.6%). Twenty-six different genotypes (40.6%) were predicted to be BH(4)-responsive, represented by 38 different families (35.5%).
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Phenylalanine hydroxylase deficiency in the Slovak population: genotype-phenotype correlations and genotype-based predictions of BH4-responsiveness.Gene. 2013 Sep 10;526(2):347-55. doi: 10.1016/j.gene.2013.05.057. Epub 2013 Jun 10. Gene. 2013. PMID: 23764561
-
Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase (PAH) deficiency.Mol Genet Metab. 2009 Jul;97(3):165-71. doi: 10.1016/j.ymgme.2009.03.009. Epub 2009 Apr 1. Mol Genet Metab. 2009. PMID: 19394257 Clinical Trial.
-
Phenylalanine hydroxylase deficiency in south Italy: Genotype-phenotype correlations, identification of a novel mutant PAH allele and prediction of BH4 responsiveness.Clin Chim Acta. 2015 Oct 23;450:51-5. doi: 10.1016/j.cca.2015.07.014. Epub 2015 Jul 23. Clin Chim Acta. 2015. PMID: 26210745
-
Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria.Hum Mutat. 2013 Jul;34(7):927-36. doi: 10.1002/humu.22320. Epub 2013 May 1. Hum Mutat. 2013. PMID: 23559577 Review.
-
Structural studies on phenylalanine hydroxylase and implications toward understanding and treating phenylketonuria.Pediatrics. 2003 Dec;112(6 Pt 2):1557-65. Pediatrics. 2003. PMID: 14654665 Review.
Cited by 13 articles
-
Anthropometry and bone mineral density in treated and untreated hyperphenylalaninemia.Endocr Connect. 2020 Jul;9(7):649-657. doi: 10.1530/EC-20-0214. Endocr Connect. 2020. PMID: 32520722 Free PMC article.
-
Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases.EBioMedicine. 2020 Apr;54:102730. doi: 10.1016/j.ebiom.2020.102730. Epub 2020 Apr 16. EBioMedicine. 2020. PMID: 32305867 Free PMC article.
-
Screening of PAH Common Mutations in Chinese Phenylketonuria Patients Using iPLEX MALDI-TOF MS.ACS Omega. 2020 Jan 17;5(4):1805-1812. doi: 10.1021/acsomega.9b02955. eCollection 2020 Feb 4. ACS Omega. 2020. PMID: 32039316 Free PMC article.
-
Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia.PLoS One. 2019 Jan 22;14(1):e0211048. doi: 10.1371/journal.pone.0211048. eCollection 2019. PLoS One. 2019. PMID: 30668579 Free PMC article. Clinical Trial.
-
Analysis of EX5del4232ins268 and EX5del955 PAH gene mutations in Ukrainian patients with phenylketonuria.Genes Dis. 2016 Dec 14;4(2):108-110. doi: 10.1016/j.gendis.2016.11.004. eCollection 2017 Jun. Genes Dis. 2016. PMID: 30258912 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Medical